Introduction
The Australia-SH antigen has been recently described in sera collected from patients with acute hepatitis during the incubation period or early acute phase of the illness, and from 13 to 80% of the patients studied have been found to carry this antigen (Okochi and Murakami, 1968; Prince, 1968; Gocke and Kavey, 1969; London, Sutnick, and Blumberg, 1969; Levene and Blumberg, 1969) .
In all those studies the antigen was demonstrated by the immunodiffusion technique in agar or agarose gel. The serum containing antibody was usually obtained from patients who had received many blood transfusions. It may be that in these patients repeated exposure to the hepatitis agent through receiving large quantities of blood may result in the production of a specific precipitating antibody. The antigen so detected has been referred to as the Australia antigen (Au(1)) (Blumberg, Sutnick, and London, 1968) , the SH antigen (Prince, 1968) , and the hepatitis antigen (Gocke and Kavey, 1969 The following comparisons of the indicator-sera have been made. At the School of Hygiene all of the antisera used gave lines of identity when tested against a "reference" Australia-SH antigen (Patient T.) supplied by Dr. R. W. McCollum. In the Virus Reference Laboratory the three sera used gave lines of identity when tested against a reference Australia antigen (C045378) supplied by Dr. B. S. Blumberg. The sera were titrated in doubling dilutions against the same antigen. Anti-Au (1) and serum L.B. gave similar endpoints of 1/16, but anti-SH could not be diluted beyond 1/2. When testing patients' sera for the presence of antigen the detector sera were used undiluted except for donor F., which was used 3 x -concentrated, and Sanders which was 4 x -concentrated.
Inmunodiffusion Technique
In each laboratory agarose gels were prepared by the method of Prince (1968) . This agarose was dissolved in a buffer composed of 0-1 M sodium chloride, 0 01 M tris (hydroxymethyl) aminomethanol (pH 7 6 at 250 C.), 0.001 M ethylenediamine/ tetra acetic acid containing 1 mg. of protamine sulphate per ml. At the School of Hygiene merthiolate was added to the gel to give a final concentration of 1/5,000.
A similar pattern of six equivalent wells surrounding a centre well were used in both laboratories. At the School of Hygiene the tests were performed in 190-mm. Sterilin plastic Petri dishes with 2 5-mm. wells 4 mm. apart and a gel volume of 15 ml., 756 27 eptmbe199HAntigBen-Cossart et al.
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Australia-SH Anie-osr ta.MEDICALJORA whereas in the Virus Reference Laboratory 1 ml. of gel on a standard microscope slide was used and the wells were 2 mm. in diameter and S mm. apart.
Gels were stored for at least 24 hours at 40 C. before use. After the addition of the test sera they were kept in a moist chamber at room temperature and read daily for four days (Virus Reference Laboratory) and seven days (School of Hygiene).
Results
Details of the 27 patients examined for the presence of Australia-SH antigen are given in Table I . The patients had abnormal serum aspartate aminotransferase (S.G.O.T.) and raised total bilirubin levels in their serum. Sera obtained soon after admission to hospital from 11 of the 27 patients were found to contain the antigen. None of the convalescent sera were positive. The intensity of the precipitin lines was graded subjectively ±, +, + +, +++ Absence of a detectable precipitin line is denoted by-.
When the results of the two laboratories were compared (Table II) (Gocke and Kavey, 1969) that earlier specimens are more likely to contain antigen no significant difference was found in this study between the proportion of positive sera collected in the first 12 days of illness, 6 out of 11, and the proportion of positive sera collected between the 13th and 30th days, 5 out of 11.
The lines of precipitation between the same antigen and the different antisera varied in intensity. In three instances one serum failed to detect antigen in specimens positive with the others.
Comment
The Australia-SH antigen had been found in widely scattered geographical areas (Blumberg et al., 1968) , and in this series it has been present in 11 (40%) out of 27 patients with viral hepatitis examined in England.
The cases were not classified as either "infectious" or " serum " hepatitis. Prince (1968) found the antigen in 11 out of 15 cases of hepatitis following blood transfusion, but he failed to find it in five patients with infectious hepatitis. Gocke and Kavey (1969) , on the other hand, reported that 80% of their patients in both categories possessed the antigen in their sera. Wright, McCollum, and Klatskin (1969) found 25% of infectious hepatitis patients positive by this test.
A major reason for the wide variation in incidence of the antigen is likely to be the difference in the criteria adopted for making the clinical distinction between infectious and serum hepatitis. It is probably not due to technical factors nor to differences in the specificity of the antisera. This is supported by the close agreement in this study between the results obtained independently by the two laboratories testing the same clinical specimens under somewhat varying conditions, and using five indicator-sera. These sera, derived both from persons living in the United States and in this country, detected antigen in the sera of the same 11 persons in the present series.
In agreement with the observations of Okochi and Murakami (1968), London et al. (1969) , and Gocke and Kavey (1969) the presence of the antigen in the sera of patients with viral hepatitis appears to be transient during the acute phase of the disease, since the antigen was not detected in sera collected during convalescence.
